A landmark study presented today at ESCMID Global 2025 has revealed that over 3 million children worldwide lost their lives in 2022 due to antimicrobial resistance (AMR)-related infections. VIENNA, April 12, 2025 /PRNewswire/ -- The study underscores the urgent need for both regional and global strategies to control paediatric AMR, particularly in high-burden areas such as South-East Asia and Africa. AMR poses a critical threat to children, who are highly vulnerable to infections. Access to new

CHENGDU, China, April 12, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") today announced that results from a Phase 3 registrational clinical study evaluating the novel TROP2 antibody drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) for the treatment of adult patients with advanced triple-negative breast cancer (TNBC) and results from an early Phase I/II clinical study of sac-TMT for the treatment of adult patients with advanced non-small-cell lung ca

Welcome back to Endpoints Weekly! This week’s recap kicks off with Andrew Dunn’s examination of the biotech playbook for surviving market turmoil. As former Alnylam CEO John Maraganore put it, recent events have “put biotech CEOs in a very difficult set of shoes compared to what we’ve had to deal with in the past.” See below for more details on how companies might handle the uncertainty. Meanwhile, our reporters tracked news on potential pharma-specific tariffs, which President Donald Trump said

Delay Gives Trump Administration Time to Further Evaluate Coverage Policy and Payment Reform WASHINGTON, April 11, 2025 /PRNewswire/ -- The MASS Coalition applauds the Trump Administration's decision to delay the effective date for the Medicare Local Coverage Determinations (LCDs) restricting access to skin substitute products to January 1, 2026. This action by President Trump, HHS Secretary Kennedy, and CMS Administrator Dr. Oz will enable the new Administration to formulate a revised coverage

The Company Expects the Continued Sale of OPKO-Branded Products in China but is Pausing Activities for Future US-Produced Products Including its Florida Sunshine Brand of Vitamins and Supplements Due to Tariff Impact COCONUT GROVE, Fla., April 11, 2025 /PRNewswire/ -- NextPlat Corp (NASDAQ: NXPL, NXPLW) ("NextPlat" or the "Company"), a global e-Commerce provider, today provided an update on the impact of current United States/China tariffs on its e-Commerce development program as a result of Chi

According to a study published in the European Journal of Cancer, the fairness and equity of datasets for AI-driven mammogram interpretation might be jeopardized by the underrepresentation of racial and ethnic diversity. While AI shows promise for enhancing how mammograms are interpreted, particularly in areas where resources are limited, the study's authors found warning signs regarding the diversity of datasets and the representation of researchers in AI model development, which they said coul

BRIDGEWATER, N.J., April 11, 2025 /PRNewswire/ -- Hamamatsu Photonics, a global leader in whole slide imaging and spatial proteomics solutions, is pleased to announce a strategic partnership with Sirona Dx (SDX) as its Technology Access Partner. This collaboration will streamline the technology evaluation process by providing customers with access to deep spatial biology expertise within a GCLP / CLIA accredited laboratory for imaging, staining, and bioinformatics analysis, removing barriers to

Bipartisan senators introduced the Health Tech Investment Act (S. 1399), which would establish a Medicare reimbursement pathway for FDA-cleared medical devices that utilize artificial intelligence and machine learning. The bill, introduced by Sens. Mike Rounds, R-S.D., and Martin Heinrich, D-N.M., seeks to amend title XVIII of the Social Security Act to "ensure appropriate payment of certain algorithm-based healthcare services under the Medicare program." Through the bill, the Secretary of Heal

MIAMI, April 11, 2025 /PRNewswire/ -- Thomas J. Utset-Ward, MD, has joined the Nicklaus Children's Orthopedic, Sports Medicine & Spine Institute as a pediatric orthopedic surgeon specializing in pediatric orthopedic oncology. His focus is the surgical treatment of benign and malignant tumors of the bone and soft tissues, such as sarcoma, as well as complex limb-sparing reconstructions. Additionally, he specializes in pediatric arthroplasty for children and teens in need of joint replacement surg

Through the Technology in Space Prize, two startups will receive more than $650,000 in total funding and the ability to leverage the ISS National Lab to advance their R&D BOSTON, April 11, 2025 /PRNewswire/ -- Startups RedPoint Oncology and Fourier are the newest recipients of the Technology in Space Prize, funded by Boeing and the Center for the Advancement of Science in Space® (CASIS®), manager of the International Space Station (ISS) National Laboratory. Selected through the M assChallenge (